Skip to main content
Caplight Logo









Pharmarack

Pharmarack

Private
PuneEnterprise Softwarehttps://pharmarack.com/

Last Round

Series A

Sep 23, 2019

Total Funding Raised

$3.28M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Pharmarack is a healthcare technology company that provides a SaaS-based platform to automate and streamline the pharmaceutical supply chain.

Sector

Enterprise Software

Verticals

Pharma Supply Chain, Vertical SaaS, Healthcare Analytics, Logistics Software, Digital Payments

Business Model

B2B

Customer Profile

Subscription SaaS, Marketplace Commission, Data as a Service, Payment Processing Fee, Services & Consulting

AI Layer

Application

Keywords

pharma supply chainpharma techB2B marketplacevertical SaaSinventory managementorder management systempharma data analyticsB2B commerce platformsupply chain financingworking capital financingdigital payment solutionsdata as a serviceDaaS

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Pharmarack Comparables

Compare Pharmarack with similar companies based on industry and business-model similarity.

Pharmarack comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Medibox Digital Solutions Private Limited
83%
PharmEasy
80%
Pharmahook
79%

Pharmarack Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series ASep 23, 2019
VC RoundSep 22, 2016
SeedFeb 1, 2016

Key People

Founding team and executive leadership

Amit Kaul

Chief Operating Officer, Chief Product, Technology an Operations Officer

Executive Team

Pharmarack Investors

Notable investors and investment history

Pharmarack investors
InvestorRounds
Unicorn India VenturesVC Round, Seed
IvyCap VenturesSeries A
Currae Healthtech FundVC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 29, 2026

    Monthly visitors increased 40% MoM.

  • Jun 22, 2026

    Monthly visitors grew 502% MoM, reaching 6.8K.

Pharmarack Filings

Explore SEC and related filing metadata, where available.

Pharmarack filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Pharmarack's valuation, stock price, and market status.

Is Pharmarack a public or private company?

Pharmarack is a private company.

What is the current stock price of Pharmarack?

Pharmarack is a private company with no public stock price. No recent secondary market data is available.

How much is Pharmarack worth (valuation)?

Valuation information for Pharmarack is not publicly available.

Can I buy Pharmarack stock?

Pharmarack shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Pharmarack's last funding round?

Funding round information for Pharmarack is not publicly available.

Who are the main investors in Pharmarack?

Investor information for Pharmarack is not publicly disclosed.

Will Pharmarack IPO soon?

No public IPO plans have been announced for Pharmarack.

How can I track Pharmarack secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Pharmarack's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersPune
Employee Range733
Year Founded2015
Last FundingSep 23, 2019

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?